If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say there isn’t enough evidence it works.
from NYT > Top Stories https://ift.tt/2SWS5su
June 06, 2021 at 03:27AM
0 Comments